Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer.

Published

Journal Article

Full Text

Cited Authors

  • Saylor, PJ; Keating, NL; Freedland, SJ; Smith, MR

Published Date

  • February 2011

Published In

Volume / Issue

  • 71 / 3

Start / End Page

  • 255 - 261

PubMed ID

  • 21319864

Pubmed Central ID

  • 21319864

Electronic International Standard Serial Number (EISSN)

  • 1179-1950

International Standard Serial Number (ISSN)

  • 0012-6667

Digital Object Identifier (DOI)

  • 10.2165/11588930-000000000-00000

Language

  • eng